Modifiable risk factors for Serious Mental Illness - an integrated program of epidemiology, genetics and clinical trials

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1056929

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

John McGrath has discovered that vitamin D during brain development is associated with psychosis. Just as the use of folate decreased the incidence of spina bifida, vitamin D supplementation could decrease the incidence of psychosis. Using international samples, McGrath will search for modifiable risk factors for mental illness related to nutrition, infection and stress. He will use the latest methods from genetics to explore modifiable risk factors and undertake clinical trials.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2018

Funding Scheme: Targeted Calls

Funding Amount: $3,750,000.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Neurosciences not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

clinical trial | early psychosis | epidemiology | genetic epidemiology | schizophrenia and related disorders | vitamin D

Related Links